Low Rate of Clinically Evident Extravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with a Complement C5 Inhibitor: Results from a Large, Multicenter, US Real-World Study.
Jamile ShammoAjeet GajraYogesh PatelIoannis TomazosJonathan K KishAnita HillJ Rafael SierraDavid AratenPublished in: Journal of blood medicine (2022)
A range of hematologic causes need to be considered when evaluating anemia in the presence of treatment with a C5 inhibitor.